Remember that they have a subsidiary in Ireland, and as for why would you do it elsewhere -- if "elsewhere" is paying for it, or has an easier time coming up with patients for it. It may be immensely cheaper in some other country to do this trial.

It's not a good idea to make assumptions. Mr. Ehrlich has done things that surprised us many times in the past -- like, for instance, setting up the Irish subsidiary.